RespireRx Pharmaceuticals Inc. (OTCMKTS:RSPI – Get Free Report) was the recipient of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 22,000 shares, a decrease of 73.1% from the March 31st total of 81,700 shares. Based on an average daily trading volume, of 7,859,600 shares, the days-to-cover ratio is currently 0.0 days.
RespireRx Pharmaceuticals Stock Performance
Shares of OTCMKTS:RSPI remained flat at $0.00 during trading on Thursday. 420,000 shares of the stock were exchanged, compared to its average volume of 12,124,260. RespireRx Pharmaceuticals has a 1 year low of $0.00 and a 1 year high of $0.02. The stock has a market capitalization of $673,973.34, a PE ratio of -0.04 and a beta of 0.49.
RespireRx Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than RespireRx Pharmaceuticals
- What is a Special Dividend?
- Hasbro’s Management Made All the Right Calls This Quarter
- Health Care Stocks Explained: Why You Might Want to Invest
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Best Stocks Under $10.00
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for RespireRx Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RespireRx Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.